Clinical Trial

Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma

Study acronym: PRECODOM
Recruiting
View on ClinicalTrials.gov →
Summary
Prostate adenoma management includes, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. The minimum duration of hospitalization, in the context of enucleation prostatic endoscopy by laser, is estimated at 48 hours. The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses. This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by nurses allows reducing hospital stay length without increasing the risk of serious complications for patients
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-06-12; most recent amendment 2025-11-18.
Status change: Not Yet Recruiting → Recruiting 2024-04-17
Trial Details
NCT Number NCT05912764
Lead Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions Adenoma
Enrollment 440 participants
Start Date 2024-01-26
Primary Completion 2027-08-15 (estimated)
Study Completion 2027-08-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-24